NCT01913600View on ClinicalTrials.gov

Resolute Integrity US Extended Length Sub-Study(RI US XL)

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2018

Conditions
Coronary Artery Disease
Interventions
DEVICE

Resolute Integrity Stent

Drug eluting stent (DES)

Trial Locations (1)

13203

St. Joseph's Hospital Health Center, Syracuse

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT01913600 - Resolute Integrity US Extended Length Sub-Study(RI US XL) | Biotech Hunter | Biotech Hunter